Provention Bio Appoints Jason Hoitt as Chief Commercial Officer

OLDWICK, N.J., Jan. 8, 2020 -- (Healthcare Sales & Marketing Network) -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced the appointment of ... Biopharmaceuticals, Personnel Provention Bio, immunotherapy, diabetes, celiac disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news